Overview: Zydus Wellness is a leading Indian consumer wellness company with a global footprint is a subsidiary of the pharmaceutical company Cadila Healthcare. Headquartered in Ahmedabad and Mumbai, Zydus Wellness have 5 manufacturing facilities across 4 locations – Aligarh, Sitarganj.Ahmedabad and Sikkim and also have 8 co-packing facilities in India, Oman and Newzealand. Today the Zydus Wellness business spans over 20 countries and 3 continents.

Stock Name : Zydus Wellness Ltd Buy : 2092 Posted Date : JUNE 29, 2021
Stopless : 2025 Target : 2205

About the company: Carnation Nutra-Analogue Foods was founded in 1994 as a producer of dairy substitutes. In 2006, Zydus Cadila acquired a 14.96% stake in the company and within 2 years,Cadila's stake in the company increased to over 70%, after the merger of Cadila's consumer goods business, which included sugar substitute brand Sugar Free and EverYuth range of skincare products,into Carnation. The merged entity was then named as Zydus Wellness Limited.

In January 2019, Zydus Wellness acquired a part of Heinz India's business for ₹4,595 crore, which included the health drink brand Complan, glucose-based energy drink additive Glucon D, talcum powder brand Nycil and Sampriti Ghee.

Currently, Zydus Wellness has seven leading brands in their portfolio, namely Complan, Sugar Free,Glucon-D, Everyuth, Nycil, Sugarlite and Nutralite.

For the Financial Year 2020-21, E-commerce grew by more than 250% accounting for almost 3.6% of the domestic revenue. International business, which accounts for more than 3% of the consolidated revenues, also grew by 200% during the year with the company making entry in countries like Nigeria and Taiwan.

Shareholding Pattern:
 Promoters: 64.82%
 Foreign Institutions: 2.76%
 N Banks Mutual Funds: 7.73%
 Others: 2.7%
 General Public: 4.76%
 Financial Institutions: 17.23%

Management: Mr. Tarun G. Arora is the CEO and Dr. Sharvil P. Patel is the Non – Executive Chairman of Zydus.

Sales Report: Zydus Wellness has reported a Consolidated Total Income of Rs 607.52 Crore for the quarter ended on March 31 2021, which is up 58.17 % from last quarter Total Income of Rs 384.10 Crore and up 24.19 % from last year same quarter Total Income of Rs 489.17 Crore. The company reported 92.7% jump in net profit to Rs 133.13 crore in this quarter against Rs 69.10 crore in Q4 FY20.

If you find any mistake please contact the support@largecapindia.com. This article is general in nature. It does not constitute a recommendation to buy and sell any stock, and does not take account of your objectives, or your financial situation. Largecapindia has no position in the stocks mentioned.Largecapindia aim to bring you long term focused research analysis driven by fundamental thanks.